RHYTHM PHARMACEUTICALS, INC. (RYTM)
Clinical trial NCT05813704 updates: 1. status: UNKNOWN → COMPLETED 2. completion date: 2025-05-01 → 2024-08-19 3. primary completion date: 2025-04-01 → 2024-07-19 4. enrollment: 156 → 159 participants 5. enrollment type: ESTIMATED → ACTUAL 6. collaborators added: LanZhou University 7. collaborators removed: Lanzhou University First Hospital
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical